Attend BioIVT’s special workshop on methods to assess BSEP inhibition and integrate BSEP studies into your IND strategy. BSEP is an important hepatic efflux transporter and BSEP inhibition has been associated with drug-induced liver toxicity. Guidance from regulatory agencies recommends inclusion of BSEP inhibition data in IND submissions.
This complimentary event will provide a “road map” for studies needed for an IND submission. And we’ll discuss new models and methods with improved IVIVE correlation that can help address regulators’ questions.
Join us for these presentations and a discussion on best practices to advance your leads to the clinic.
- Practical advice on conducting BSEP inhibition studies
- Recommendations for your IND submission strategy
- Network with industry colleagues
Read more details about the presentations in each session here.
Registration is required to attend.
If you have any questions, feel free email us at email@example.com.